1
|
Dolatabadi S, Ahmadi B, Rezaei-Matehkolaei A, Zarrinfar H, Skiada A, Mirhendi H, Nashibi R, Niknejad F, Nazeri M, Rafiei A, Gharaghani M, Erami M, Taghipour S, Piri F, Makimura K. Mucormycosis in Iran: A six-year retrospective experience. J Mycol Med 2018; 28:269-273. [PMID: 29545123 DOI: 10.1016/j.mycmed.2018.02.014] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2017] [Revised: 02/24/2018] [Accepted: 02/24/2018] [Indexed: 01/24/2023]
Abstract
Mucormycosis is a devastating infection caused by Mucoralean fungi (Mucormycotina, Mucorales). Data concerning the global epidemiology of mucormycosis are scarce and little is known about the characteristics of mucormycosis in Iran. In this study, we aimed to understand the distribution of this infection in Iran retrospectively and to ascertain whether the patterns of infection are associated with specific host factors or not. A total of 208 cases were included in this study occurring during 2008-2014 and were validated according to (EORTC/MSG) criteria. A rising trend as significant increase from 9.7% in 2008 to 23.7% in 2014 was observed. The majority of patients were female (51.4%) with median age of 50 and the infections were seen mostly in autumn season (39.4%). Diabetes mellitus (75.4%) was the most common underlying condition and sinus involvement (86%) was the mostly affected site of infection. Amphotericin B (AmB) was the drug of choice for the majority of cases. Sixty four isolates did not show any growth in the lab and only 21 cases were evaluated by ITS sequencing, among them; Rhizopus arrhizus var. arrhizus was the dominant species. Considering the high mortality rate of mucormycosis, early and accurate diagnosis, with the aid of molecular methods may provide accurate treatments and improve the survival rate. Therefore, increased monitoring and awareness of this life-threatening disease is critical.
Collapse
Affiliation(s)
- S Dolatabadi
- Faculty of Engineering, Sabzevar University of New Technology, Sabzevar, Iran
| | - B Ahmadi
- Department of Medical Laboratory Sciences, School of Para-Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
| | - A Rezaei-Matehkolaei
- Department of Medical Mycology, School of Medicine, Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
| | - H Zarrinfar
- Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - A Skiada
- Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece
| | - H Mirhendi
- Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
| | - R Nashibi
- Health Research Institute, Infectious and Tropical Diseases Research Center, Infectious Diseases Department, Razi Teaching Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - F Niknejad
- Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran
| | - M Nazeri
- Department of Medical Parasitology and Mycology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
| | - A Rafiei
- Department of Medical Mycology, School of Medicine, Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - M Gharaghani
- Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
| | - M Erami
- Shahid Beheshti Hospital, Kashan University of Medical Sciences, Kashan, Iran
| | - S Taghipour
- Department of Medical Parasitology and Mycology, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
| | - F Piri
- Department of Medical Mycology, School of Medicine, Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - K Makimura
- Division of Clinical Laboratory Medicine, Graduate School of Medical Care and Technology, Laboratory of Space and Environmental Medicine, Graduate School of Medicine, Teikyo University, Tokyo, Japan
| |
Collapse
|
2
|
Zargaran M, Taghipour S, Kiasat N, Aboualigalehdari E, Rezaei-Matehkolaei A, Zarei Mahmoudabadi A, Shamsizadeh F. Luliconazole, an alternative antifungal agent against Aspergillus terreus. J Mycol Med 2017; 27:351-356. [PMID: 28483449 DOI: 10.1016/j.mycmed.2017.04.011] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2017] [Revised: 04/09/2017] [Accepted: 04/10/2017] [Indexed: 11/29/2022]
Abstract
Aspergillus terreus is the fourth leading cause of invasive and non-invasive aspergillosis and one of the causative agents of morbidity and mortality among immunocompromised and high-risk patients. A. terreus appears to have increased as a cause of opportunistic fungal infections from superficial to serious invasive infections. Although, invasive aspergillosis is often treated empirically with amphotericin B, most A. terreus isolates are resistant both in vivo and in vitro to some antifungal drugs. In this study, we aimed to evaluate antifungals susceptibility profiles of the different strains of A. terreus against amphotericin B, caspofungin, fluconazole, voriconazole, posaconazole and luliconazole. Forty A. terreus strains originating from environmental sources (air and soil) were identified using by macroscopic and microscopic features. Six antifungals including, amphotericin B, caspofungin, fluconazole, voriconazole, posaconazole and luliconazole were applied for susceptibility tests. Our results show that tested isolates had different susceptibility to antifungals. The lowest MICGM related to luliconazole (0.00236μg/ml), followed by posaconazole (0.18621μg/ml), voriconazole (0.22925μg/ml), caspofungin (0.86μg/ml), fluconazole (8μg/ml) and amphotericin B (11.12μg/ml). This study demonstrated that luliconazole had an excellent in vitro activity against all tested isolates of A. terreus, with MICGM 0.00236μg/mL than other tested antifungals. As a result, luliconazole could be a possible alternative antifungal for the treatment of aspergillosis due to A. terreus.
Collapse
Affiliation(s)
- M Zargaran
- Infectious and tropical diseases research center, health research institute, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran; Department of medical mycology, school of medicine, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran
| | - S Taghipour
- Department of medical mycology, school of medicine, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran
| | - N Kiasat
- Department of medical mycology, school of medicine, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran
| | - E Aboualigalehdari
- Department of medical mycology, school of medicine, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran
| | - A Rezaei-Matehkolaei
- Infectious and tropical diseases research center, health research institute, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran; Department of medical mycology, school of medicine, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran
| | - A Zarei Mahmoudabadi
- Infectious and tropical diseases research center, health research institute, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran; Department of medical mycology, school of medicine, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran.
| | - F Shamsizadeh
- Department of medical mycology, school of medicine, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran
| |
Collapse
|
3
|
Karimi-Zarchi M, Ezabadi MG, Hekmatimoghaddam S, Mortazavizade M, Taghipour S, Vahidfar M, Vahedian H, Forat M, Shamsi F, Miratashi-Yazdi A. Cancer in pregnancy: a 10-year experience in shahid sadoughi hospital, yazd, iran. Int J Biomed Sci 2013; 9:168-173. [PMID: 24170992 PMCID: PMC3809349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Figures] [Subscribe] [Scholar Register] [Received: 05/20/2013] [Accepted: 06/20/2013] [Indexed: 06/02/2023]
Abstract
INTRODUCTION Although occurrence of cancer during pregnancy is rare, it leads to high morbidity and mortality in both mother and fetus. Recent trends in prolongation of child-bearing age have made cancer-associated pregnancies more frequent than past. As yet there are few documents concerning cancer and its related treatment outcomes during pregnancy. This study aimed at describing clinical characteristics of pregnant women with cancer in the Shahid Sadoughi hospital in Yazd, Iran. MATERIALS AND METHODS Case series were reviewed retrospectively, which included 19 pregnant women diagnosed with cancer in Shahid Sadoughi hospital from 2002 to 2012. Data collected comprised demographics, pregnancy characteristics and outcomes, type of cancer, clinical stage, treatment and oncological. RESULTS From 17 pregnant women with cancer, 4 women had gynecologic cancers and 13 had non-gynecologic cancers. The Following tumors were observed: breast [6], acute myeloblastic leukemia [3], uterine cervix carcinoma [3], ovary [1], chronic myelogenous leukemia [1], lymphoma [1], papillary carcinoma of thyroid [1], and pseudopapillary carcinoma of pancreas [1]. The mean age of patients was 30.6 years, and the mean gestational age at diagnosis was 21.1 weeks. Surgical treatment was performed in 3 patients, 6 patients were treated by chemotherapy, and in 3 by both. DISCUSSION Although cancer during pregnancy is uncommon, it is considered an important problem due to unsuitable maternal and fetal outcomes and lack of standard management guidelines. Our cases represent examples of feasible or justifiable managements for them.
Collapse
Affiliation(s)
- M. Karimi-Zarchi
- Department of Gynecological Oncology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
| | | | - S. Hekmatimoghaddam
- Department of laboratory sciences, school of paramedicine, Shahid Sadoughi University of medical sciences, Yazd, Iran
| | - M. Mortazavizade
- Department of Gynecological Oncology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
| | - S. Taghipour
- Department of pathology, school of medicine, Shahid Sadoughi University of medical sciences, Yazd, Iran
| | - M. Vahidfar
- Department of internal medicine, school of medicine, Shahid Sadoughi University of medical sciences, Yazd, Iran
| | - H. Vahedian
- Department of internal medicine, school of medicine, Shahid Sadoughi University of medical sciences, Yazd, Iran
| | - M. Forat
- Department of internal medicine, school of medicine, Shahid Sadoughi University of medical sciences, Yazd, Iran
| | - F. Shamsi
- Department of biostatistics and epidemiology, school of health, Shahid Sadoughi University of medical sciences, Yazd, Iran
| | - A. Miratashi-Yazdi
- Internal Medicine, Azada University of Medical Science, Yazd Branch, Iran
| |
Collapse
|
4
|
Binesh F, Taghipour S, Navabii H. Focal myositis of the thigh misdiagnosed radiologically as rhabdomyosarcoma. BMJ Case Rep 2011; 2011:2011/mar31_1/bcr1220103574. [PMID: 22700615 DOI: 10.1136/bcr.12.2010.3574] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Focal myositis is a commonly referenced, infrequently reported and poorly documented benign inflammatory pseudotumour, which may be misdiagnosed as a malignant tumour. We report the clinicopathologic features in a case of focal myositis in the thigh of a 15-year-old boy.
Collapse
Affiliation(s)
- F Binesh
- Department of Pathology, Shahid Sadoghi Hospital, Yazd Shahid Sadoghi University, Yazd, Iran
| | | | | |
Collapse
|